Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2011
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivityTimothy J Wilkin, Mathew Bidwell Goetz, Robert Leduc, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384Gregory K Robbins, John G Spritzler, Ellen S Chan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjectsGail Skowron, John G Spritzler, Jodi Weidler, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 StudyBabafemi O Taiwo, Ellen S Chan, Carl J Fichtenbaum, et al.The Journal of Infectious Diseases|September 13, 2014
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286Allan R Tenorio, Ellen S Chan, Ronald J Bosch, et al.Journal of AIDS & Clinical Research|November 4, 2015
Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207Jane Hitti, Elias K Halvas, Lu Zheng, et al.The Journal of Infectious Diseases|January 29, 2003
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046sHernan Valdez, Ronald Mitsuyasu, Alan Landay, et al.Plos One|December 25, 2013
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabineNicholas T Funderburg, Adriana Andrade, Ellen S Chan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIVDeborah K McMahon, Lu Zheng, Jane Hitti, et al.AIDS (London, England)|June 10, 2016
Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovirEllen S Chan, Alan L Landay, Todd T Brown, et al.Pageof 3